146 related articles for article (PubMed ID: 1206740)
1. Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide. I. Variation in administration of both agents.
Fisher B; Wolmark N; Rubin H; Saffer E
J Natl Cancer Inst; 1975 Nov; 55(5):1147-53. PubMed ID: 1206740
[TBL] [Abstract][Full Text] [Related]
2. Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide. II. Effect of cortisone acetate.
Fisher B; Rubin H; Saffer E; Wolmark N
J Natl Cancer Inst; 1976 Mar; 56(3):571-4. PubMed ID: 1255788
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of prolonged Corynebacterium parvum and cyclophosphamide administration on the growth of established tumors.
Fisher B; Wolmark N; Saffer E; Fisher ER
Cancer; 1975 Jan; 35(1):134-43. PubMed ID: 1109767
[TBL] [Abstract][Full Text] [Related]
4. Comparative effects of Corynebacterium parvum, Brucella abortus extract, Bacillus Calmette-Guérin, glucan, levamisole, and tilorone with or without cyclophosphamide on tumor growth, macrophage production, and macrophage cytotoxicity in a murine mammary tumor model.
Fisher B; Gebhardt M
Cancer Treat Rep; 1978 Nov; 62(11):1919-30. PubMed ID: 728912
[TBL] [Abstract][Full Text] [Related]
5. Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide. III. Effect of C. parvum on cyclophosphamide metabolism.
Fisher B; Wolmark N; Rubin H
J Natl Cancer Inst; 1976 Jul; 57(1):225-6. PubMed ID: 1003505
[TBL] [Abstract][Full Text] [Related]
6. The effect of Corynebacterium parvum in combination with 5-fluorouracil, L-phenylalanine mustard, or methotrexate on the inhibition of tumor growth.
Fisher B; Rubin H; Saffer E; Wolmark N
Cancer Res; 1976 Aug; 36(8):2714-9. PubMed ID: 1277181
[TBL] [Abstract][Full Text] [Related]
7. Effects of dose and schedule of immune stimulant on efficacy of combination Corynebacterium parvum-cyclophosphamide treatment for a murine mammary adenocarcinoma.
Purnell DM; Bartlett GL; Kreider JW
Cancer Res; 1979 Jan; 39(1):1-5. PubMed ID: 761179
[TBL] [Abstract][Full Text] [Related]
8. Comparative antitumor effects of Corynebacterium parvum, Bordetella pertussis, Bacillus Calmette-Guérin, and levamisole alone or in combination with cyclophosphamide in the CaD2 murine mammary adenocarcinoma system.
Purnell DM; Bartlett GL; Kreider JW; Biro TG; Kontra J
Cancer Res; 1979 Dec; 39(12):4838-42. PubMed ID: 498111
[TBL] [Abstract][Full Text] [Related]
9. Further observations on the inhibition of tumor growth by C. parvum with cyclophosphamide. VII. Effect of treatment prior to primary tumor removal on the growth of distant tumor.
Fisher B; Gebhardt M; Saffer E
Cancer; 1979 Feb; 43(2):451-8. PubMed ID: 421172
[TBL] [Abstract][Full Text] [Related]
10. Response of tumors to biologic modifiers and chemotherapeutic agents.
Katsuoka Y; deKernion JB
Tokai J Exp Clin Med; 1983 May; 8(2):175-85. PubMed ID: 6658848
[TBL] [Abstract][Full Text] [Related]
11. Effect of continuous administration of interleukin 2 on active specific chemoimmunotherapy with extracted tumor-specific transplantation antigen and cyclophosphamide.
Naito K; Pellis NR; Kahan BD
Cancer Res; 1988 Jan; 48(1):101-8. PubMed ID: 3257158
[TBL] [Abstract][Full Text] [Related]
12. Correlation of antitumor chemoimmunotherapy with bone marrow macrophage precursor cell stimulation and macrophage cytotoxicity.
Fisher B; Wolmark N
Cancer Res; 1976 Jul; 36(7 PT 1):2241-7. PubMed ID: 1277129
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the inhibition of tumor growth following local or systemic administration of Corynebacterium parvum or other immunostimulating agents with or without cyclophosphamide.
Fisher B; Gebhardt M; Linta J; Saffer E
Cancer Res; 1978 Sep; 38(9):2679-87. PubMed ID: 679170
[No Abstract] [Full Text] [Related]
14. Combined radiotherapy and Corynebacterium parvum treatment of a murine fibrosarcoma.
Collins AL; Song CW
Radiology; 1977 Oct; 125(1):235-41. PubMed ID: 897175
[TBL] [Abstract][Full Text] [Related]
15. Corynebacterium parvum and cyclophosphamide as combination treatment for a murine mammary adenocarcinoma.
Purnell DM; Bartlett GL; Kreider JW; Biro TG
Cancer Res; 1977 Apr; 37(4):1137-40. PubMed ID: 844041
[TBL] [Abstract][Full Text] [Related]
16. Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide--VIII.
Fisher B; Gebhardt MC; Saffer EA
Int J Radiat Oncol Biol Phys; 1978; 4(11-12):975-82. PubMed ID: 721660
[No Abstract] [Full Text] [Related]
17. Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide. IX. Macrophage content of tumors in mice.
Gebhardt MC; Fisher B
J Natl Cancer Inst; 1979 Apr; 62(4):1035-41. PubMed ID: 285276
[No Abstract] [Full Text] [Related]
18. Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide. X. Effect of treatment on tumor cell kinetics in mice.
Fisher B; Gunduz N
J Natl Cancer Inst; 1979 Jun; 62(6):1545-51. PubMed ID: 286125
[No Abstract] [Full Text] [Related]
19. Effect of Corynebacterium parvum on the response to irradiation of a C3H fibrosarcoma.
Suit HD; Sedlacek R; Wagner M; Orsi L; Silobrcic V; Rothman KJ
Cancer Res; 1976 Apr; 36(4):1305-14. PubMed ID: 1260756
[TBL] [Abstract][Full Text] [Related]
20. Corynebacterium parvum as an immunotherapeutic agent in an ovarian cancer model.
Knapp RC; Berkowitz RS
Am J Obstet Gynecol; 1977 Aug; 128(7):782-6. PubMed ID: 560124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
